CONSORT MEDICAL LIMITED

00406711
Active Cheadle

Manufacture of medical and dental instruments and supplies

0 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesActivities of head offices
C

CONSORT MEDICAL LIMITED

00406711

Manufacture of medical and dental instruments and supplies

Founded 22 Mar 1946 Active Cheadle, United Kingdom 0 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesActivities of head offices

Previous Company Names

CONSORT MEDICAL PLC 3 Oct 2007 — 31 Jul 2020
BESPAK PLC 11 Nov 1982 — 3 Oct 2007
BESPAK INDUSTRIES LIMITED 22 Mar 1946 — 11 Nov 1982
Accounts Submitted 19 Dec 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 17 Nov 2025 Next due 24 Nov 2026 5 months remaining
Net assets £201M £11M 2023 year on year
Total assets £326M £7M 2023 year on year
Total Liabilities £125M £4M 2023 year on year
Charges 4
1 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

Pure Offices Suite 71 Brooks Drive Cheadle Royal Business Park Cheadle SK8 3TD United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CONSORT MEDICAL LIMITED (00406711), an active life sciences and medical technology company based in Cheadle, United Kingdom. Incorporated 22 Mar 1946. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£3.00k

Decreased by £609.00k (-100%)

Net Assets

£200.93M

Increased by £10.89M (+6%)

Total Liabilities

£124.79M

Decreased by £3.55M (-3%)

Turnover

N/A

Employees

N/A

Debt Ratio

38%

Decreased by 2 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

86 Allotments 612,646 Shares £3.50m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Mar 202015,954£123k£7.74
13 Mar 201939£354.12£9.08
5 Dec 2018198£2k£9.08
23 Nov 2018991£9k£9.08
29 Oct 2018272£3k£9.21

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Recipharm Holdings Limited
100.0%
53,511,874

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Mar 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CONSORT MEDICAL LIMITED Current Company

Charges

Charges

1 outstanding 3 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Suite B, Breakspear Park, Breakspear Way, Hemel Hempstead DACORUM
Leasehold-16 Jan 2017
Suite B, Breakspear Park, Breakspear Way, Hemel Hempstead
Leasehold
Added 16 Jan 2017
District DACORUM

Documents

Company Filings

DateCategoryDescriptionDocument
19 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
9 Dec 2025Persons With Significant ControlChange to Recipharm Holdings Limited as a person with significant control on 8 Dec 2025
17 Nov 2025Confirmation StatementConfirmation statement made on 10 Nov 2025 with updates
24 Jun 2025InsolvencySolvency Statement dated 24/06/25
24 Jun 2025CapitalStatement by Directors
19 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

9 Dec 2025 Persons With Significant Control

Change to Recipharm Holdings Limited as a person with significant control on 8 Dec 2025

17 Nov 2025 Confirmation Statement

Confirmation statement made on 10 Nov 2025 with updates

24 Jun 2025 Insolvency

Solvency Statement dated 24/06/25

24 Jun 2025 Capital

Statement by Directors

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

6 months ago on 19 Dec 2025

Change to Recipharm Holdings Limited as a person with significant control on 8 Dec 2025

6 months ago on 9 Dec 2025

Confirmation statement made on 10 Nov 2025 with updates

7 months ago on 17 Nov 2025

Solvency Statement dated 24/06/25

1 years ago on 24 Jun 2025

Statement by Directors

1 years ago on 24 Jun 2025